Concepedia

Richard E. Kast

RE

Statistics

Publications

54

Citations

1.8K

H-Index

25

Active since

1974

Affiliations

University of Vermont(Current)

Universität Ulm

Columbia University Irving Medical Center

University Hospital Ulm

Icahn School of Medicine at Mount Sinai

Richard E. Kast is an author at University of Vermont specializing in medicine, pharmacology, and glioma.

ORCID

Top concepts

Publications per year

1974–2024

54

Publications

54

A new chapter opens in anti-inflammatory treatments:The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

D. Brustolim, Ricardo Ribeiro‐dos‐Santos, Richard E. Kast et al. · International Immunopharmacology · 2006 · 195 citations · Full text

, , +11

Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide

Joanna Triscott, Cathy Lee, Kaiji Hu et al. · Oncotarget · 2012 · 138 citations · Full text

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

Richard E. Kast, Georg Karpel‐Massler, Marc‐Eric Halatsch · Oncotarget · 2014 · 115 citations · Full text

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

Marc‐Eric Halatsch, Richard E. Kast, Georg Karpel‐Massler et al. · Neuro-Oncology Advances · 2021 · 65 citations · Full text

Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels

Richard E. Kast · General Hospital Psychiatry · 2003 · 63 citations

, , +13

Rows per page

1–5 of 54